Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Michetti

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Journal of Crohn'S & Colitis|January 28, 2014
Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitisMichel H Maillard, Murielle Bortolotti, John-Paul Vader, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT IIChristian Felley, John-Paul Vader, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT IIChristian Mottet, John-Paul Vader, Christian Felley, et al.
The American Journal of Gastroenterology|June 18, 2019
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel DiseaseLaure F Pittet, Charlotte M Verolet, Pierre Michetti, et al.
The American Journal of Gastroenterology|August 28, 2013
Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rateAlain M Schoepfer, Mohamed-Ali Dehlavi, Nicolas Fournier, et al.
Vaccine|November 27, 2002
Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pyloriStavros Sougioultzis, Cynthia K Lee, Mazen Alsahli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 30, 2014
Addressing current treatment challenges in Crohn's disease in real life: a physician's surveyStephan R Vavricka, Sanja Radivojevic, Christine N Manser, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT IIPascal Juillerat, John-Paul Vader, Christian Felley, et al.
Inflammatory Bowel Diseases|July 20, 2017
Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC)Jessica Pepe, Sophie Zawadynski, Francois R Herrmann, et al.
Digestion|August 29, 2019
Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based ConsensusThomas Greuter, Michel H Maillard, Pascal Juillerat, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Journal of Crohn'S & Colitis|January 28, 2014
Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitisMichel H Maillard, Murielle Bortolotti, John-Paul Vader, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT IIChristian Felley, John-Paul Vader, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT IIChristian Mottet, John-Paul Vader, Christian Felley, et al.
The American Journal of Gastroenterology|June 18, 2019
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel DiseaseLaure F Pittet, Charlotte M Verolet, Pierre Michetti, et al.
The American Journal of Gastroenterology|August 28, 2013
Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rateAlain M Schoepfer, Mohamed-Ali Dehlavi, Nicolas Fournier, et al.
Vaccine|November 27, 2002
Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pyloriStavros Sougioultzis, Cynthia K Lee, Mazen Alsahli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 30, 2014
Addressing current treatment challenges in Crohn's disease in real life: a physician's surveyStephan R Vavricka, Sanja Radivojevic, Christine N Manser, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT IIPascal Juillerat, John-Paul Vader, Christian Felley, et al.
Inflammatory Bowel Diseases|July 20, 2017
Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC)Jessica Pepe, Sophie Zawadynski, Francois R Herrmann, et al.
Digestion|August 29, 2019
Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based ConsensusThomas Greuter, Michel H Maillard, Pascal Juillerat, et al.
Pageof 15